Lixing Li

1.6k total citations · 1 hit paper
51 papers, 984 citations indexed

About

Lixing Li is a scholar working on Economics and Econometrics, Political Science and International Relations and Molecular Biology. According to data from OpenAlex, Lixing Li has authored 51 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Economics and Econometrics, 14 papers in Political Science and International Relations and 9 papers in Molecular Biology. Recurrent topics in Lixing Li's work include Local Government Finance and Decentralization (10 papers), Corporate Finance and Governance (7 papers) and China's Socioeconomic Reforms and Governance (7 papers). Lixing Li is often cited by papers focused on Local Government Finance and Decentralization (10 papers), Corporate Finance and Governance (7 papers) and China's Socioeconomic Reforms and Governance (7 papers). Lixing Li collaborates with scholars based in China, United States and Hong Kong. Lixing Li's co-authors include Xiaoyu Wu, Guangrong Ma, Zhangkai Huang, Lixin Colin Xu, Guangsu Zhou, Xuezheng Qin, Lingsheng Meng, Chee‐Ruey Hsieh, Yangyang Liu and Yi Zhou and has published in prestigious journals such as Journal of Biological Chemistry, American Economic Review and Diabetes.

In The Last Decade

Lixing Li

49 papers receiving 956 citations

Hit Papers

Hayek, Local Information, and Commanding Heights: Decentr... 2017 2026 2020 2023 2017 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lixing Li China 17 348 263 224 172 128 51 984
Jane Leber Herr United States 6 514 1.5× 232 0.9× 237 1.1× 146 0.8× 77 0.6× 10 1.2k
Pedro H. C. Sant’Anna United States 9 636 1.8× 275 1.0× 133 0.6× 92 0.5× 128 1.0× 19 1.4k
Matthew D. Webb Canada 9 476 1.4× 254 1.0× 113 0.5× 100 0.6× 65 0.5× 19 1.1k
Xinzheng Shi China 16 662 1.9× 202 0.8× 140 0.6× 55 0.3× 121 0.9× 46 1.3k
Tiago Cavalcanti United Kingdom 21 1.0k 3.0× 313 1.2× 184 0.8× 189 1.1× 94 0.7× 56 1.6k
Doruk Cengiz United States 3 609 1.8× 187 0.7× 310 1.4× 79 0.5× 58 0.5× 5 1.1k
Ben Zipperer United States 8 866 2.5× 259 1.0× 333 1.5× 117 0.7× 77 0.6× 18 1.4k
Li Gan United States 17 599 1.7× 203 0.8× 232 1.0× 51 0.3× 49 0.4× 80 1.0k
Salvador Navarro United States 15 738 2.1× 304 1.2× 210 0.9× 101 0.6× 36 0.3× 27 1.4k
Attila Lindner United Kingdom 6 842 2.4× 195 0.7× 362 1.6× 115 0.7× 69 0.5× 16 1.4k

Countries citing papers authored by Lixing Li

Since Specialization
Citations

This map shows the geographic impact of Lixing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixing Li more than expected).

Fields of papers citing papers by Lixing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixing Li. The network helps show where Lixing Li may publish in the future.

Co-authorship network of co-authors of Lixing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lixing Li. A scholar is included among the top collaborators of Lixing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixing Li. Lixing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yan-Chun, Lixing Li, Jiaqing Xiang, et al.. (2025). TRIM65 as a key regulator of ferroptosis and glycolysis in lactate-driven renal tubular injury and diabetic kidney disease. Cell Reports. 44(8). 116091–116091. 2 indexed citations
2.
Xiang, Jiaqing, Guangyan Yang, Lixing Li, et al.. (2025). Lactate orchestrates the TGFβ pathway and ferroptosis nexus in organ fibrosis via USP2 lactylation. Communications Biology. 8(1). 1855–1855.
3.
Yang, Shu, et al.. (2025). Deubiquitinating enzyme USP2 alleviates muscle atrophy by stabilizing PPARγ. Diabetes. 74(5). 773–786. 2 indexed citations
4.
Zhang, Wenwen, et al.. (2025). USP43-mediated HSPA8 deubiquitination alleviates diabetic kidney disease. Biochemical and Biophysical Research Communications. 775. 152177–152177. 1 indexed citations
6.
Yang, Shu, Kewei Jiang, Ying Peng, et al.. (2025). Colchicine inhibits vascular calcification by suppressing inflammasome activation through the enhancement of the Sirt2-PP2Ac signaling pathway. Journal of Biological Chemistry. 301(7). 110381–110381. 1 indexed citations
7.
Ma, Chuanrui, Yuanli Chen, Jiaqing Xiang, et al.. (2025). HSPA8 dampens SCAP/INSIG split and SREBP activation by reducing PKR-mediated INSIG phosphorylation. Cell Reports. 44(3). 115339–115339. 7 indexed citations
8.
Yang, Shu, Guangyan Yang, Jiaqing Xiang, et al.. (2024). KLF13 restrains Dll4‐muscular Notch2 axis to improve the muscle atrophy. Journal of Cachexia Sarcopenia and Muscle. 15(5). 1869–1882. 1 indexed citations
10.
Yang, Shu, Xinyu Wang, Lixing Li, et al.. (2023). MicroRNA‐92b in the skeletal muscle regulates exercise capacity via modulation of glucose metabolism. Journal of Cachexia Sarcopenia and Muscle. 14(6). 2925–2938. 4 indexed citations
12.
Wang, Shuojia, Guangyan Yang, Xiaohao Wang, et al.. (2023). The relationship between sarcopenia and mortality in Chinese community-dwelling adults: a 7-year cohort study with propensity score matching and Mendelian randomization. Frontiers in Endocrinology. 14. 1215512–1215512. 6 indexed citations
13.
Xie, Xuanli, Lixing Li, & Guangsu Zhou. (2022). Economic inequality and entrepreneurship: Micro‐evidence from China. Strategic Entrepreneurship Journal. 17(1). 160–185. 14 indexed citations
14.
Li, Minhan, et al.. (2022). Hypoxia-related LncRNAs signature predicts prognosis and is associated with immune infiltration and progress of head and neck squamous cell carcinoma. Biochemistry and Biophysics Reports. 31. 101304–101304. 2 indexed citations
15.
Li, Lixing, et al.. (2020). Evading by any means? VAT enforcement and payroll tax evasion in China. Journal of Economic Behavior & Organization. 185. 770–784. 24 indexed citations
16.
Li, Lixing, Ying Chen, Jinyan Zhang, et al.. (2019). Vitamin D supplementation could reduce the risk of acute cellular rejection and infection in vitamin D deficient liver allograft recipients. International Immunopharmacology. 75. 105811–105811. 27 indexed citations
17.
Li, Lixing, et al.. (2011). Son Preferences,Women's Intra-Household Bargaining Power and Its Impacts on Nutrition and Health. China Economic Quarterly. 1 indexed citations
18.
Li, Lixing. (2010). The incentive role of creating “cities” in China. China Economic Review. 22(1). 172–181. 56 indexed citations
19.
Li, Lixing. (2008). Employment Burden, Government Ownership and Soft Budget Constraints: Evidence from a Chinese Enterprise Survey. SSRN Electronic Journal. 1 indexed citations
20.
Li, Lixing. (2007). Employment burden, government ownership and soft budget constraints: Evidence from a Chinese enterprise survey. China Economic Review. 19(2). 215–229. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026